Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment

Journal of Psychiatric Research

Volumn 37, Issue 3, 2003, Pages 261-262

  Moeller, Olaf ^a   Hetzel, Guenter ^a   Rothermundt, Matthias ^a   Michael, Nikolaus ^a   Nyhuis, Peter W ^a   Suslow, Thomas ^a   Arolt, Volker ^a   Erfurth, Andreas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DIAZEPAM; PROLACTIN; REBOXETINE; ZALEPLON;

BRAIN FUNCTION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; HUMAN; LETTER; MONOAMINERGIC SYSTEM; PATIENT SELECTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM;

ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; HUMANS; MONOAMINE OXIDASE; MORPHOLINES; PROLACTIN; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0037400838     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(02)00102-4     Document Type: Letter

References (7)

1. Attenburrow M.J., Mitter P.R., Whale R., Terao T., Cowen P.J. Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology. 155:2001;323-326.
2. Kapitany T., Schindl M., Schindler S.D. The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Research. 88:1999;75-88.
3. O'Keane V., McLoughlin D., Dinan T.G. d-Fenfluramine-induced prolactin and cortisol release in major depression. response to treatment Journal of Affective Disorders. 26:1992;143-150.
4. Schule C., Laakmann G., Baghai T. The influence of reboxetine on anterior pituitary hormone secretion in healthy subjects. Lopez-Ibor J.J.et al. Abstracts of the XI World Congress of Psychiatry. 1999;59 World Psychiatric Association, Hamburg.
5. Seifritz E., Baumann P., Muller M.J., Annen O., Amey M., Hemmeter U., Hatzinger M., Chardon F., Holsboer-Trachsler E. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology. 14:1996;253-263.
6. Shapira B., Reiss A., Kaiser N., Kindler S., Lerer B. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. Journal of Affective Disorders. 16:1989;1-4.
7. Wittchen HO, Pfister H. Diagnostisches Expertensystem für psychische Storungen DIA-X. In: Zeitlinger By. SWETS Test Services Frankfurt 1997.